NGT HealthCare II is an early stage venture capital fund focused on medical devices and life sciences technologies. The fund actively invests in promising technologies and promotes equal opportunities for Arab entrepreneurs within Israel's vibrant medical startup ecosystem. NGT HealthCare II seeks out entrepreneurs from the Arab society, including researchers, doctors, and scientists in the medical fields. The fund also emphasizes the employment of Arab men and women, ensuring their integration into the employment market. NGT's portfolio companies are all aligned with Sustainable Development Goal 3 (SDG 3), which focuses on good health and well-being.

NGT HealthCare II benefits from a significant risk reduction mechanism through high non-dilutive leverage via the Innovation Authority. The fund maintains close relationships with leading universities, hospitals, and research institutions, providing a rich flow of investment opportunities. Additionally, NGT's wide network with multinational corporations enables it to create value for its portfolio companies. Structured as an impact fund and located in Nazareth, NGT aligns with three UN Sustainable Development Goals (SDGs).

The fund is led by Livnat Ben Zur, who brings over 20 years of experience in the medical device and healthcare industries. Her extensive knowhow includes spearheading global product development projects, leading global business development efforts, and managing complex product portfolios from design development through clinical and production phases to commercial launch.

Keywords: venture capital, medical devices, life sciences, Arab entrepreneurship, Israel, SDG 3, impact fund, Innovation Authority, investment opportunities, multinational corporations.